Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Clinical Utility of tACS in the Treatment of Anxious Arousal and Sensory Sensitivity

NCT03305328 is registered in ClinicalTrials.gov with Florida State University as lead sponsor.

NCT NCT03305328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03305328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Clinical Utility of tACS in the Treatment of Anxious Arousal and Sensory Sensitivity
Lead sponsor
Florida State University
Phase
Not applicable
Overall status
Completed
Start date
July 29, 2016
Completion date
March 31, 2017
Enrollment
38 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders and symptoms, hypervigilance, post traumatic stress disorder, sensory disorders